Company Profiles

driven by the PitchBook Platform

HemoShear Therapeutics

Description

Developer of technologies to replicate the biology of organ systems and diseases. The company focuses on discovering novel biological targets and developing drugs to treat children's rare metabolic disorders.

2008

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$18.2M

Total Amount Raised

4

Investors

Description

Developer of technologies to replicate the biology of organ systems and diseases. The company focuses on discovering novel biological targets and developing drugs to treat children's rare metabolic disorders.

Website:

www.hemoshear.com

Formerly Known As

HemoShear

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

501 Locust Avenue Suite 301 Charlottesville, VA 22902United States +1 (434) 872-0196
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore HemoShear Therapeutics's full profile, request a free trial.

HemoShear Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

HemoShear Therapeutics Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Ed WilliamsAngel (individual)Minority000 0000000 0000
Main Line Equity PartnersPE/BuyoutMinority000 0000000 0000
United States Small Business AdministrationLimited Partner000 0000000 0000
Virginia Capital PartnersVenture CapitalMinority000 0000000 0000
Ed Williams Angel (individual)
Main Line Equity Partners PE/Buyout
United States Small Business Administration Limited Partner
Virginia Capital Partners Venture Capital

HemoShear Therapeutics Executive Team (11)

NameTitleBoard
Seat
Contact
Info
James PowersChief Executive Officer & Chairman
Richard White Jr.Vice President, Finance & Controller
Svetlana MarukianDirector, Immunology and Platform Modalities
Aaron MackeyDirector of Quantitative and Computational Science
David MankaDirector of Translational Science
James Powers Chief Executive Officer & Chairman
Richard White Jr. Vice President, Finance & Controller
Svetlana Marukian Director, Immunology and Platform Modalities
Aaron Mackey Director of Quantitative and Computational Science
David Manka Director of Translational Science

HemoShear Therapeutics Board Members (7)

NameRepresentingRoleSinceContact
Info
James PowersHemoShear TherapeuticsChief Executive Officer & Chairman000 0000
John Brooks IIISelfBoard Member000 0000
Mehmood Khan MDSelfBoard Member000 0000
Reginald WoodsSelfBoard Member000 0000
Robert Gould Ph.DHemoShear TherapeuticsBoard Member000 0000
James Powers Chief Executive Officer & Chairman HemoShear Therapeutics
John Brooks III Board Member Self
Mehmood Khan MD Board Member Self
Reginald Woods Board Member Self
Robert Gould Ph.D Board Member HemoShear Therapeutics
Request full access to PitchBook